Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with stomach cancer receiving FOLFOX4 regimen.

Sang Yeob Kim,Yunsuk Choi,Y. Seol,Moo Gon Song,H. Shin,Joo Seop Chung,G. J. Cho

Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with stomach cancer receiving FOLFOX4 regimen.

2011

Sang Yeob Kim
Yunsuk Choi
Y. Seol
Moo Gon Song
H. Shin
Joo Seop Chung
G. J. Cho

e19580 Background: Palonosetron, a unique second generation 5-HT3RA, has demonstrated superiority in preventing both acute and delayed emesis when compared with the first-generation 5-HT3RAs. The a...

Keywords:

Palonosetron
Stomach cancer
Anesthesia
Regimen
Physical therapy
Medicine
Chemotherapy-induced nausea and vomiting
Internal medicine
Gastroenterology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations